In addition, we found that MSLN-CAR T cells maintained transient antitumor activity but failed to achieve tumor control, possibly due to the limited antigen expression in SNU119 cells and the low percentage of CD3+ cells in the peripheral circulation (Figure S3). Here, MSLN is linked to neoplasm.